{
  "zip": "33431",
  "sector": "Healthcare",
  "longBusinessSummary": "Connectyx Technologies Holdings Group, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. Connectyx Technologies Holdings Group, Inc. was founded in 1995 and is based in Boca Raton, Florida.",
  "city": "Boca Raton",
  "phone": "561-418-7725",
  "state": "FL",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.connectyx.com",
  "maxAge": 1,
  "address1": "1825 NW Corporate Boulevard",
  "industry": "Health Information Services",
  "address2": "Suite 110",
  "previousClose": 0.044,
  "regularMarketOpen": 0.0449,
  "twoHundredDayAverage": 0.02043319,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0449,
  "navPrice": null,
  "averageDailyVolume10Day": 2947847,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.044,
  "fiftyDayAverage": 0.03198121,
  "trailingAnnualDividendRate": null,
  "open": 0.0449,
  "averageVolume10days": 2947847,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 442.11868,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0401,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 1177514,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 13986000,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3348761,
  "priceToSalesTrailing12Months": 105.695114,
  "dayLow": 0.0401,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1177514,
  "fiftyTwoWeekHigh": 0.0556,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0005,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0449,
  "exchange": "PNK",
  "shortName": "CONNECTYX TECHNOLOGIES HLDGS GR",
  "longName": "Curative Biotechnology, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CTYX",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_44676669",
  "uuid": "a88f3dff-5b1b-32d9-910e-2e7cdf2b3b85",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 107.472,
  "beta3Year": null,
  "profitMargins": -0.58884996,
  "enterpriseToEbitda": -249.298,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 0,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1419984000,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -77919,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1483142400,
  "mostRecentQuarter": 1585612800,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": null,
  "enterpriseValue": 14221186,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1282521600,
  "lastSplitFactor": "1:50",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0449,
  "logo_url": "https://logo.clearbit.com/connectyx.com"
}